0
Skip to Content
Watertown Bio
Home
Newsletter
Community Overview
Organization Gallery
Therapeutic Pipeline Overview
Industry Reports
About
Contact
Support Us
Support Watertown Bio
Watertown Bio
Home
Newsletter
Community Overview
Organization Gallery
Therapeutic Pipeline Overview
Industry Reports
About
Contact
Support Us
Support Watertown Bio
Home
Newsletter
Folder: Life Science Community Info
Back
Community Overview
Organization Gallery
Therapeutic Pipeline Overview
Industry Reports
Folder: About Us
Back
About
Contact
Support Us
Support Watertown Bio
Watertown's First Potential IPO since 2023, Remix's Positive Clinical Trial Results, and Triveni Jumps into the Eczema Market
News Roundup Sam Ghilardi 5/26/26 News Roundup Sam Ghilardi 5/26/26

Watertown's First Potential IPO since 2023, Remix's Positive Clinical Trial Results, and Triveni Jumps into the Eczema Market

Plus the initial dosing of Enanta and Avencell's Clinical Trials

Read More
ALS TDI moves to Arsenal Yards, Windgap Medical’s Big Pharma Collab, and Watertown’s Q1 fundraising numbers
News Roundup Sam Ghilardi 4/28/26 News Roundup Sam Ghilardi 4/28/26

ALS TDI moves to Arsenal Yards, Windgap Medical’s Big Pharma Collab, and Watertown’s Q1 fundraising numbers

Plus the initial dosing of Enanta Plus Addgene’s rebrand and Earth Day clean upsAvencell's Clinical Trials

Read More
Watertown's Emerging Rare Blood Disorder Therapy Cluster, Warning Signs For Werewolf, and Fallout for Disc Medicines-Watertown Bio News RoundUp
News Roundup Sam Ghilardi 3/3/26 News Roundup Sam Ghilardi 3/3/26

Watertown's Emerging Rare Blood Disorder Therapy Cluster, Warning Signs For Werewolf, and Fallout for Disc Medicines-Watertown Bio News RoundUp

Join us next week in Charting Watertown’s Life Science Future

Read More

Watertown Bio

Contact

info@watertown.bio